Pediatrics
Conference Coverage
Dupilumab safe, effective in kids 6-11 with moderate-to-severe asthma
Adding the dupilumab option for children in this age group is 'huge.'
Conference Coverage
New agents for youth-onset type 2 diabetes ‘finally in sight’
‘A number of clinical trials of antidiabetic pharmacologic agents in diabetic youth have been completed, demonstrating safety and efficacy, and a...
Commentary
Rising rates of T1D in children: Is COVID to blame?
With the pandemic came a noticeable rise in cases of new-onset type 1 diabetes in children. Dr. Jessica Sparks Lilley discusses possible...
Opinion
Respiratory infection– and asthma-prone children
The pathogenesis, development, severity, and clinical outcomes of respiratory infections are largely dependent on the resident composition of the...
Conference Coverage
Study eyes impact of isotretinoin on triglycerides, other lab measures
“Clinicians must weigh the laboratory values with the costs of laboratory testing, including opportunity costs such as time, monetary costs, and...
News
FDA rejects teplizumab for type 1 diabetes delay
The decision follows narrow endorsement by an advisory panel.
News from the FDA/CDC
New COVID-19 vaccinations decline again in 12- to 15-year-olds
New weekly cases of COVID-19 in children have dropped to their lowest level since May of 2020.
Conference Coverage
Omnipod 5 ‘artificial pancreas’ shows benefit in type 1 diabetes
If approved by the FDA, it would be the third commercially available semiautomated insulin delivery system in the United States and the first...
Conference Coverage
Intervention opens access to care for minority youths with type 1 diabetes
Program adds support for children with diabetes and their families who are struggling because of lack of resources or marginalization in the...
Conference Coverage
‘Staggering’ doubling of type 2 diabetes in children during pandemic
Two new studies show a shocking increase in type 2 diabetes among U.S. children during the pandemic, with increased severity at presentation....